Business Standard

Board of Advanced Enzyme Technologies approves acquisition of additional 15% stake in JC Biotech

Image

Capital Market

At meeting held on 29 May 2021

The Board of Advanced Enzyme Technologies at its meeting held on 29 May 2021 has approved the acquisition of additional stake of 15% of equity share capital of JC Biotech by purchase of 31,06,680 equity shares for consideration of Rs 21.12 crore. On completion of the acquisition, the company's shareholding in JC Biotech will increase from 70% to 85%.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 29 2021 | 3:29 PM IST

Explore News